For example, the evaluation of Epidermal Growth Factor Receptor (EGFR) expression is highly necessary for therapeutic planning of anti-EGFR drugs in patients with lung or oral cancer (33). This evidence concerns the gene EGFR and lip and oral cavity carcinoma.